Kemp Andrew H, Quintana Daniel S, Quinn Candice R, Hopkinson Patrick, Harris Anthony W F
Discipline of Psychiatry, Sydney Medical School, University of Sydney Sydney, NSW, Australia ; School of Psychology, Faculty of Science, University of Sydney Sydney, NSW, Australia ; Centro de Pesquisa Clínica e Epidemiológica, Hospital Universitário - Universidade de São Paulo São Paulo, Brazil.
School of Psychology, Faculty of Science, University of Sydney Sydney, NSW, Australia ; NORMENT, K.G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo Oslo, Norway ; Division of Mental Health and Addiction, Oslo University Hospital Oslo, Norway.
Front Psychol. 2014 Nov 27;5:1387. doi: 10.3389/fpsyg.2014.01387. eCollection 2014.
Major depressive disorder (MDD) is associated with increased heart rate and reductions in its variability (heart rate variability, HRV) - markers of future morbidity and mortality - yet prior studies have reported contradictory effects. We hypothesized that increases in heart rate and reductions in HRV would be more robust in melancholia relative to controls, than in patients with non-melancholia.
A total of 72 patients with a primary diagnosis of MDD (age M: 36.26, SE: 1.34; 42 females) and 94 controls (age M: 35.69, SE: 1.16; 52 females) were included in this study. Heart rate and measures of its variability (HRV) were calculated from two 2-min electrocardiogram recordings during resting state. Propensity score matching controlled imbalance on potential confounds between patients with melancholia (n = 40) and non-melancholia (n = 32) including age, gender, disorder severity, and comorbid anxiety disorders.
MDD patients with melancholia displayed significantly increased heart rate and lower resting-state HRV (including the square root of the mean squared differences between successive N-N intervals, the absolute power of high frequency and standard deviation of the Poincaré plot perpendicular to the line of identity measures of HRV) relative to controls, findings associated with a moderate effect size (Cohens d's = 0.56-0.58). Patients with melancholia also displayed an increased heart rate relative to those with non-melancholia (Cohen's d = 0.20).
MDD patients with melancholia - but not non-melancholia - display robust increases in heart rate and decreases in HRV. These findings may underpin a variety of behavioral impairments in patients with melancholia including somatic symptoms, cognitive impairment, reduced responsiveness to the environment, and over the longer-term, morbidity and mortality.
重度抑郁症(MDD)与心率加快及其变异性(心率变异性,HRV)降低有关,而HRV是未来发病和死亡的指标,但先前的研究报告了相互矛盾的结果。我们假设,与非忧郁症患者相比,忧郁症患者心率加快和HRV降低的情况会比对照组更明显。
本研究共纳入72例初步诊断为MDD的患者(年龄中位数:36.26,标准误:1.34;42例女性)和94名对照组(年龄中位数:35.69,标准误:1.16;52例女性)。在静息状态下,通过两份2分钟的心电图记录计算心率及其变异性(HRV)指标。倾向得分匹配控制了忧郁症患者(n = 40)和非忧郁症患者(n = 32)之间在年龄、性别、疾病严重程度和共病焦虑症等潜在混杂因素上的不平衡。
与对照组相比,患有忧郁症的MDD患者心率显著加快,静息状态下的HRV较低(包括连续N-N间期平方差的平方根、高频绝对功率以及庞加莱图垂直于恒等线测量的HRV标准差),这些结果与中等效应量相关(科恩d值 = 0.56 - 0.58)。与非忧郁症患者相比,忧郁症患者的心率也有所增加(科恩d值 = 0.20)。
患有忧郁症的MDD患者——而非非忧郁症患者——表现出心率显著加快和HRV降低。这些发现可能是忧郁症患者各种行为障碍的基础,包括躯体症状、认知障碍、对环境反应性降低,以及长期的发病和死亡风险。